Effect of Baseline Symptom Manifestations on Retention in Care and Treatment among HIV-Infected Patients in Nigeria.


Journal

Journal of the International Association of Providers of AIDS Care
ISSN: 2325-9582
Titre abrégé: J Int Assoc Provid AIDS Care
Pays: United States
ID NLM: 101603896

Informations de publication

Date de publication:
Historique:
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 20 5 2021
Statut: ppublish

Résumé

Symptom management is an important component of HIV care. But symptom patterns and how they affect engagement with HIV care and treatment services have not been adequately explored in the era of increased HIV treatment scale-up. We investigated the relationship between symptom patterns among people living with HIV (PLHIV) and 12 months retention in care, within the context of other clinical and demographic characteristics. Retrospective cohort analysis of 5114 PLHIV receiving care within a large HIV treatment program in Nigeria. We assessed the prevalence and burden of baseline symptoms reported during routine clinic visits from January 2015 to December 2017. Multivariable regression was used to identify relationships between 12-month retention and symptom dimensions (prevalence and burden) while controlling for demographic and other clinical variables. Increasing symptom burden was associated with higher likelihood of retention at 12 months (adjusted odds ratio [aOR] = 1.19 [95% confidence interval, CI: 1.09-1.29];

Sections du résumé

BACKGROUND
Symptom management is an important component of HIV care. But symptom patterns and how they affect engagement with HIV care and treatment services have not been adequately explored in the era of increased HIV treatment scale-up. We investigated the relationship between symptom patterns among people living with HIV (PLHIV) and 12 months retention in care, within the context of other clinical and demographic characteristics.
METHODS
Retrospective cohort analysis of 5114 PLHIV receiving care within a large HIV treatment program in Nigeria. We assessed the prevalence and burden of baseline symptoms reported during routine clinic visits from January 2015 to December 2017. Multivariable regression was used to identify relationships between 12-month retention and symptom dimensions (prevalence and burden) while controlling for demographic and other clinical variables.
RESULTS
Increasing symptom burden was associated with higher likelihood of retention at 12 months (adjusted odds ratio [aOR] = 1.19 [95% confidence interval, CI: 1.09-1.29];

Identifiants

pubmed: 32027211
doi: 10.1177/2325958220903575
pmc: PMC7005974
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2325958220903575

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI106406
Pays : United States

Références

J Acquir Immune Defic Syndr. 2010 Aug;54(5):500-5
pubmed: 20150819
J Pain Symptom Manage. 2019 Mar;57(3):617-626
pubmed: 30465875
S Afr Med J. 2012 Mar 02;102(6):499-500
pubmed: 22668949
Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15
pubmed: 20586956
Pathog Glob Health. 2012 Mar;106(1):46-54
pubmed: 22595274
J Pain Symptom Manage. 2011 Jul;42(1):12-23
pubmed: 21429701
J Pain Symptom Manage. 2009 Dec;38(6):882-93
pubmed: 19811886
Clin J Pain. 2015 Sep;31(9):813-819
pubmed: 25329144
PLoS One. 2017 Sep 1;12(9):e0183823
pubmed: 28863160
J Pain Symptom Manage. 2001 Jan;21(1):41-51
pubmed: 11223313
Open Forum Infect Dis. 2014 Aug 06;1(2):ofu055
pubmed: 25734125
Sex Transm Infect. 2010 Dec;86(7):520-4
pubmed: 20551235
J Pain Symptom Manage. 1999 Oct;18(4):253-62
pubmed: 10534965
PLoS One. 2016 Nov 9;11(11):e0165528
pubmed: 27829033
J Pain. 2012 Jul;13(7):704-13
pubmed: 22748803
AIDS Behav. 2012 Aug;16(6):1708-15
pubmed: 21850443
PLoS One. 2019 Jul 10;14(7):e0218555
pubmed: 31291273
J Pain Symptom Manage. 2005 Feb;29(2):185-92
pubmed: 15733810
Pain Med. 2000 Sep;1(3):260-73
pubmed: 15101893
AIDS Care. 2008 Apr;20(4):442-8
pubmed: 18449821
J Pain Symptom Manage. 2017 Jul;54(1):110-119
pubmed: 28479413
J Palliat Med. 2010 Apr;13(4):375-80
pubmed: 20384499
BMC Palliat Care. 2017 Jul 13;17(1):8
pubmed: 28705181
Ann Med Health Sci Res. 2015 Nov-Dec;5(6):373-8
pubmed: 27057373
AIDS Care. 2015;27(7):817-28
pubmed: 25671515
PLoS One. 2015 May 12;10(5):e0126554
pubmed: 25966420

Auteurs

Juliet Adeola (J)

APIN Public Health Initiatives, Abuja, Nigeria.
Northwestern University Feinberg School of Medicine, Center for Health Services & Outcomes Research, Chicago, IL, USA.

Okikiolu Abimbola Badejo (OA)

APIN Public Health Initiatives, Abuja, Nigeria.
Institute of Tropical Medicine, Antwerp, Belgium.

Aimalohi Ahonkhai (A)

Vanderbilt University, Division of Infectious Diseases, Nashville, TN, USA.

Prosper Okonkwo (P)

APIN Public Health Initiatives, Abuja, Nigeria.

Patrick Aboh Akande (P)

APIN Public Health Initiatives, Abuja, Nigeria.

Charlesnika Tyon Evans (CT)

Northwestern University Feinberg School of Medicine, Center for Health Services & Outcomes Research, Chicago, IL, USA.

Megan McHugh (M)

Northwestern University Feinberg School of Medicine, Center for Health Services & Outcomes Research, Chicago, IL, USA.

Leslie Pierce (L)

Vanderbilt University, Division of Infectious Diseases, Nashville, TN, USA.

Isah Ahmed (I)

APIN Public Health Initiatives, Abuja, Nigeria.

Toyin Jolayemi (T)

APIN Public Health Initiatives, Abuja, Nigeria.

Babatunde Ladi Akinyemi (B)

APIN Public Health Initiatives, Abuja, Nigeria.

Ifeyinwa Onwuatuelo (I)

APIN Public Health Initiatives, Abuja, Nigeria.

Robert Murphy (R)

Northwestern University Feinberg School of Medicine, Center for Health Services & Outcomes Research, Chicago, IL, USA.

Demetrious Kyriacou (D)

Northwestern University Feinberg School of Medicine, Center for Health Services & Outcomes Research, Chicago, IL, USA.

Jonah Musa (J)

Jos University Teaching Hospital, APIN Center, Plateau State, Nigeria.

Patricia Agaba (P)

Jos University Teaching Hospital, APIN Center, Plateau State, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH